This quality improvement study examines disparities in proton radiotherapy use in patients enrolled in Children’s Oncology Group Trials

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411938PMC
http://dx.doi.org/10.1001/jamaoncol.2020.2259DOI Listing

Publication Analysis

Top Keywords

disparities proton
8
proton radiotherapy
8
patients enrolled
8
oncology group
8
group trials
8
race disparities
4
radiotherapy cancer
4
cancer treatment
4
treatment patients
4
enrolled children's
4

Similar Publications

Methionine-driven methylation modification overcomes plasmid-mediated high-level tigecycline resistance.

Nat Commun

January 2025

Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.

Tigecycline is a last-resort antibiotic to treat complicated infections caused by multidrug-resistant pathogens, while the emergence of plasmid-mediated tet(X) family severely compromises its clinical efficacy. Novel antimicrobial strategies not limited to new antibiotics in pharmaceutical pipeline are urgently needed. Herein, we reveal the metabolic disparities between tet(X)-negative and -positive E.

View Article and Find Full Text PDF

"Seeing Is Believing": How Neutron Crystallography Informs Enzyme Mechanisms by Visualizing Unique Water Species.

Biology (Basel)

October 2024

Department of Biological and Environmental Sciences, Samford University, Birmingham, AL 35229, USA.

Article Synopsis
  • * Neutron crystallography (NC) has emerged as a valuable tool in the 21st century for revealing hydrogen atom positions and important water molecules in enzymes, enhancing our understanding of catalytic mechanisms.
  • * This review discusses the advantages of using neutrons in studying enzymes, acknowledges the contributions of Dr. Chris G. Dealwis to the field, and presents examples of successful applications in neutron crystallography research.
View Article and Find Full Text PDF

Health Disparities and Inequities in the Utilization of Proton Therapy for Prostate Cancer.

Cancers (Basel)

November 2024

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Our study sought to review and summarize the reported health disparities and inequities in the utilization of proton beam therapy (PBT) for prostate cancer. We queried the PubMed search engine through 12/2023 for original publications examining disparate utilization of PBT for prostate cancer. The query terms included the following: prostate cancer AND proton AND (disparities OR IMRT OR race OR insurance OR socioeconomic OR inequities)".

View Article and Find Full Text PDF

Sex differences in mental rotation are a well-documented phenomenon in cognitive research, with implications for the differing prevalence of neuropsychiatric disorders such as autism spectrum disorder (ASD), Alzheimer's disease (AD) and major depressive disorder (MDD) between the sexes. Despite extensive documentation, the biological mechanism underpinning these differences remain elusive. This study aimed to elucidate neural, genetic, and molecular bases of these disparities in mental rotation by integrating data from multimodal magnetic resonance imaging (MRI), transcriptomic and receptor/transporter.

View Article and Find Full Text PDF

Purpose: To establish an ultra-high dose-rate (UHDR) radiation system using a synchrotron proton beam accelerator and to compare the effects by irradiation positions on cultured cells and chick embryos.

Methods And Materials: Protons for UHDR were obtained by applying high-frequency power at much higher levels than usual to extract all protons within approximately 50 ms. Subsequently, monitoring with a Faraday cup was performed immediately after synchrotron extraction and the waveform was adjusted accordingly.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!